Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | MRGPRX4 | Q96LA9 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 4/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.31 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | AR | P10275 | 2/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | LMNA | P02545 | 2/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.30 |
| ▸ | USP2 | O75604 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3413745 | 0.77 | AR (0.49) | PGRSLC22A12AR | |
| SCHEMBL1298904 | 0.77 | ALDH1A1 (0.40) | KDM4EMEN1MAPTKMT2ATSHR | |
| SCHEMBL6972956 | 0.73 | CNR2 (0.40) | KDM4EMAPTKMT2ANR3C1TSHR | |
| SCHEMBL4126480 | 0.73 | MAOB (0.40) | KDM4EMEN1MAPTKMT2AKCNH2 | |
| SCHEMBL11059504 | 0.73 | S100B (0.55) | KDM4EMEN1MAPTKMT2ATSHR | |
| SCHEMBL17610661 | 0.73 | MRGPRX4 (0.43) | MRGPRX4PGRKCNH2NR3C1TSHR | |
| SCHEMBL4115335 | 0.72 | ALDH1A1 (0.36) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL12107936 | 0.72 | ALDH1A1 (0.36) | KDM4EMEN1MAPTKMT2AALDH1A1 | |
| SCHEMBL18992740 | 0.70 | ALDH1A1 (0.38) | KDM4EMEN1MAPTKMT2ACYP2C9 | |
| SCHEMBL12782495 | 0.70 | CNR2 (0.42) | KDM4ETSHRALDH1A1LMNAUSP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8273797-B2 | Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-09-25 | — | — | US | disclosed |
| US-8273797-B2 | Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-09-25 | — | — | US | disclosed |
| US-8273797-B2 | Treating renal cancer using 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-2-methyl-benzaldehyde | THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2012-09-25 | — | — | US | disclosed |
| US-20110269840-A1 | TREATING RENAL CANCER USING A 4-[BIS[2-[(METHYLSULFONYL)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE | HEALTH AND HUMAN SERVICES | 2011-11-03 | — | — | US | disclosed |
| US-20110269840-A1 | TREATING RENAL CANCER USING A 4-[BIS[2-[(METHYLSULFONYL)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE | HEALTH AND HUMAN SERVICES | 2011-11-03 | — | — | US | disclosed |
| US-7989501-B2 | Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2011-08-02 | — | — | US | disclosed |
| US-7989501-B2 | Treating renal cancer using a 4-[bis[2-[(methylsulfonyl)oxy]ethyl]amino]-benzaldehyde | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2011-08-02 | — | — | US | disclosed |
| US-20090131536-A1 | Treating or Preventing Renal Cancer Using a Dimethane Sulfonate | GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131536-A1 | Treating or Preventing Renal Cancer Using a Dimethane Sulfonate | GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-05-21 | — | — | US | disclosed |
| US-20090131536-A1 | Treating or Preventing Renal Cancer Using a Dimethane Sulfonate | GOVERNMENT OF THE US, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2009-05-21 | — | — | US | disclosed |
| WO-2007044015-A9 | TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE | US GOV HEALTH & HUMAN SERV (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007044015-A9 | TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE | US GOV HEALTH & HUMAN SERV (US) | 2007-05-31 | — | — | WO | disclosed |
| WO-2007044015-A1 | TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE | GOVERNEMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-04-19 | — | — | WO | disclosed |
| WO-2007044015-A1 | TREATING OR PREVENTING RENAL CANCER USING A DIMETHANE SULFONATE | GOVERNEMENT OF THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2007-04-19 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090131536-A1 | Treating or Preventing Renal Cancer Using a Dimethane Sulfonate | VHL, DDX21, MGMT | KDM4E 74/4885MEN1 288/4885MAPT 4545/4885 |
| US-20110269840-A1 | TREATING RENAL CANCER USING A 4-[BIS[2-[(METHYLSULFONYL)OXY]ETHYL]AMINO]-2-METHYL-BENZALDEHYDE | GLS, MGMT, KDM5B | KDM4E 22/4885MEN1 1667/4885MAPT 4613/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.